At Brisbane Breast and Surgical Care, we are deeply committed to advancing the field of medicine and surgery through continuous research and education. By staying at the forefront of medical innovation, we ensure our patients receive the most up-to-date and effective treatments. We are dedicated to teaching future generations of medical professionals and foster a culture of interdisciplinary excellence delivered with compassion. We hope the care we provide will not only benefit today’s patients, but also tomorrows.
Below we outline a number of clinical trials you may have exposure to during your treatment with us and our multidisciplinary team.
PartBre-Con-Pro Study
This is an international collaborative study to evaluate surgical outcomes and the impact of radiotherapy on chest wall perforator flaps used in partial breast reconstruction following breast-conserving surgery for early breast cancer. The results of this research may guide the future treatment of breast cancer utilising chest wall perforator flaps, thus benefiting future patients and surgeons involved in their care.
TAD registry
Patients with axillary node positive breast cancer are often treated with neoadjuvant chemotherapy (treatment before surgery) and conventional axillary dissection. However, many patients experience arm morbidity and reduced quality of life with this approach and new research suggests that less radical surgical strategies may improve patient outcomes. This study will ascertain the safety and efficacy of targeted axillary dissection (TAD) as an alternative to conventional axillary dissection, in patients who undergo neoadjuvant chemotherapy. It will also collect data on breast cancer patients to help establish a new registry specifically focused on TAD treatment.
EXPERT Trial
The EXPERT trial aims to personalize radiation therapy for early breast cancer patients by using genomic testing to identify those who may safely avoid radiation after surgery. The trial, led by Breast Cancer Trials in Australia and New Zealand, focuses on women with low-risk luminal A breast cancer, using the PAM50 Assay to assess their recurrence risk. This could help minimize unnecessary treatment and side effects for eligible patients. The trial involves 1,170 participants globally, collaborating with international research groups.
Oncology Database
An online oncology database is a centralized digital platform designed to collect, organize, and analyze data related to cancer care and research. These databases are used to support clinical research, monitor treatment outcomes, and improve quality control in oncology practices. They often include information on patient demographics, tumor characteristics, treatment details, and clinical outcomes, enabling researchers and clinicians to identify trends, assess the effectiveness of treatments, and ensure adherence to evidence-based care standards. By providing real-time access to comprehensive data, these databases play a crucial role in advancing cancer research, enhancing patient care, and guiding healthcare policy.At BBSC we keep a secure online database to help us advance patient care, collate data on outcomes and ensure we comply with the gold standards of modern day breast surgery.
Optima Trial
The OPTIMA trial investigates the effectiveness of the Prosigna test in determining whether chemotherapy is necessary for patients with ER-positive, HER2-negative early breast cancer. The study aims to optimize treatment by identifying those who may not need chemotherapy, thus reducing unnecessary side effects. Participants are randomly assigned based on the test results, and the trial involves 4,500 patients globally, including at least 300 from Australia and New Zealand. The trial promotes "de-escalation" of treatment while maintaining high effectiveness.
Australian Breast Device Registry
The Australian Breast Device Registry (ABDR) is a Commonwealth-funded Monash University-led health initiative that records health data relating to breast device surgery. The registry has the purpose to monitor the long-term safety and performance of breast devices, to identify and report on possible trends and complications and the quality of surgery involving breast implants, breast tissue expanders and acellular dermal matrices and other meshes associated with breast devices.
Publications and Presentations: Dr Beth Campbell
Campbell B, Lambrianides A, Dulhunty J. Open Cholecystectomy: exposure and confidence of trainees and new fellows. International Journal of Surgery. 2018;51,218-222. DOI 10.1016/j.ijsu.2018.01.037
Campbell B, Clark D, Harvey J, Reid A. A case study of ileal metaplasia and neoplasia in a patient with an ileo-rectal anastomosis. Journal of Coloproctology. 2018; online access. DOI 10.1016/j.jcol.2017.12.006
Lewin J, Campbell B, Sanghvi KA, Skinner C, Hopkins G. Laparoscopic adjustable gastric band revisional surgery: a single surgeon series. ANZ J Surg. 2017;87(4)296-299. DOI 10.1111/ans.13359
Campbell B, Mehanna D, Stone J. Benign multicystic peritoneal mesothelioma: a rare cause of intraabdominal cystic disease. ANZ Journal Surgery 2017;87(6)15-16. DOI https://doi.org/10.1111/ans.12912
Campbell B, McBride C, Fawcett J. Unlucky versus coincidence: dual hepato-pancreatico biliary diagnosis in a six-year-old. Journal of Paediatric Case Reports 2016;(14)15-18. DOI 10.1016/j.epsc.2016.08.006
Wasinger VC, Yau Y, Duo X, Zeng M, Campbell B, Shin S, Luber R, Redmond D, Leong RW. Low mass blood peptides discriminative of Inflammatory Bowel Disease (IBD) severity: A quantitative proteomic perspective. Mol Cell Proteomics. 2016;15(1): 256-65.
Yau YY, Leong RW, Shin S, Bustamante S, Pickford R, Hejazi L, Campbell B, Wasinger VC. Bimodal plasma metabolomics strategy identified novel inflammatory metabolites in inflammatory bowel diseases. Discov Med. 2014;18(98):113-24.
Plenary Speaker: Stomal Therapy Association conference (2017). An overview of pelvic exenteration surgery: technical aspects and stoma considerations. http://www.stomaltherapyconference.com/1689
Invited Speaker RACS ASC Christchurh 2024: a. Genetics In breast cancer; b. Avoiding Bias in surgical decision making
Invited speaker BreastSUrgANZ Oncoplastic workshop 2024: How to do a subcutaneous mastectomy
Contralateral Prophylactic Mastectomy – the current evidence in 2024 E.Ipp, B Green – submitted for publication
Invited Speaker – Provincial Surgeons Association Annual Meeting, Ballarat November 2020 a. Presented – Breast Surgery Training; b. Axillary dissection – How I do It.
Molecular classification of Breast Cancer – Review. Dr. Darina Vuong, Dr. Margaret Cummings, Dr. Ben Green, Dr. Peter Smith, Prof Sunil Lakhani – Submitted for publication – World Journal of Pathology
Traumatic lumbar hernia repair: experience at the Royal Brisbane and Women’s Hospital. Chan K, Towsey K, Cavalluci D, Green B: Hernia Sept 2015
Breast Examination – Chapter review. Clinical Examination, Tally & O’Connor, 2014
Women’s Health Symposium – Updates on Breast Cancer treatment. Sofitel Brisbane, Queensland – August 2015, 2016
Familial Breast Cancer Management – Queensland Dysmorphology Meeting. Lady-Cilento Hospital Queensland – Feb 2015
Management of the Occult Breast Malignancy in Reduction Mammoplasty Specimens – Presentation. Clinical Oncology Society of Australia (COSA) Annual Meeting, Brisbane - Nov 2012
Long-term outcomes of Sentinel Lymph node biopsy in large and small breast tumours – Mater Hospital 2011 – B.Green, C. Pyke – Presented ASBD October 2011
Laparoscopic Total Colectomy in a Paediatric population November 2009. Royal Children’s Hospital , Queensland. Supervisor: Dr. Kelvin Choo - Presented Neville Davis Awards 2010
Review of Complication Post Selective Embolisation for Acute Gastrointestinal Hemorrhage. Westmead Hospital. 2005 – S. Lee, B. Green & N. Pathmanathan